Board of directors


 

Dr Alfons Nonell-Canals
Founder and Chief Executive Officer (CEO)

Bachelor's degree in Pharmacy from the University of Barcelona, PhD in Computational Chemistry from Rovira i Virgili University and a specialist in computer-aided drug design, in the development of software to modify active compounds, and in large-scale chemical and biological analyses. He is a member of the CataloniaBio research committee and sits on the board of directors of Bioinformatics Barcelona.


 

Xavier Castells
Chief Financial Officer (CFO)

CFO of InKemia IUCT Group, a biotechnology group listed on the Alternative Investment Market, and head of the IUCT Emprèn capital investment fund. He holds a Bachelor's Degree in Business Administration, an MBA from ESADE and a Master's in International Management from the Thunderbird School of Global Management (Arizona State University). He started his business career with the founding of Claranet (1996-1999) and later joined Deutsche Bank Spain (1998-2011) in its Business Client Strategy Department.


Dr Marta Príncep
Director of the Technology Department of Bellavista

She holds a PhD in Biology from the University of Barcelona, is a graduate of ESADE's Advanced Management Programme, and of the 'Global growth strategy, business opportunities and financial challenges' programme of the University of Pennsylvania. She has over 20 years' experience in executive positions in the field of life science (AdVentura Capital, Biocat and Ferrer International Group).


 

Albert Garcia-Pujadas
Co-founder and CEO of Foxize School, mentor at Connector Startup Accelerator Barcelona

Business professional with extensive experience in the fields of marketing and technology. Professor and academic coordinator of the Master's in Direct and Digital Marketing of the UPF Barcelona School of Management since 2005. Previously, he founded Ogilvy Interactive Spain and held executive positions at Nikodemo, eresMas and Intercom.


Dr Galí Drudis-Solé
Executive strategy consultant at Banc Sabadell

He began his professional career at AB-Biotics as CRO (chief research officer). After completing an MBA at ESADE, he moved to the financial sector, first at the Financial Services Authority (FSA) in London, later at Caixa Capital Risc and lastly at Banc Sabadell, where he currently works as an executive strategy consultant. He holds a Bachelor's Degree in Physics and a PhD in Theoretical Chemistry from the Autonomous University of Barcelona.